Vanguard Portfolio Management
GLSI icon

Vanguard Portfolio Management’s Greenwich LifeSciences GLSI Stock Holding History

Vanguard Portfolio Management’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Buy
80,861
+21,950
+37% +$534K ﹤0.01% 2751
2026
Q1 		$1.42M Buy
+58,911
New +$1.54M ﹤0.01% 2689

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Vanguard Portfolio Management's GLSI Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Greenwich LifeSciences (GLSI) stake by 37% in Q2 2026, buying an estimated $534K and bringing the position to 80,861 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2751.

Vanguard Portfolio Management first reported a position in GLSI in Q1 2026 and has held it in 2 quarters since. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Vanguard Portfolio Management held 80,861 shares of Greenwich LifeSciences worth $1.9M as of Q2 2026.
  • Vanguard Portfolio Management bought 21,950 Greenwich LifeSciences shares in Q2 2026, an estimated $534K.
  • Greenwich LifeSciences made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2751 holding.
  • Vanguard Portfolio Management first reported a position in Greenwich LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.